[ Search ] [ Legislation ] [ Bill Summary ]
[ Home ] [ Back ] [ Bottom ]
[ Introduced ] | [ House Amendment 001 ] | [ House Amendment 002 ] |
[ House Amendment 003 ] | [ House Amendment 005 ] |
90_HB0626eng 215 ILCS 125/2-1.1 new 215 ILCS 125/2-1.2 new 215 ILCS 125/2-1.3 new 215 ILCS 125/2-1.4 new 215 ILCS 125/2-1.5 new 215 ILCS 125/2-1.6 new 215 ILCS 125/2-1.7 new 215 ILCS 125/Art. VII heading new 215 ILCS 125/7-1 new 215 ILCS 125/7-5 new 215 ILCS 125/7-10 new 215 ILCS 125/7-15 new 215 ILCS 125/7-20 new 215 ILCS 125/7-25 new 215 ILCS 125/7-30 new 215 ILCS 125/7-35 new 215 ILCS 125/7-40 new 215 ILCS 125/4-6 rep. Amends the Health Maintenance Organization Act. Establishes requirements for disclosure of information to subscribers and enrollees. Sets forth standards for the handling of grievances by enrollees. Specifies procedures and timelines. Establishes the procedures for terminating health care professionals. Prohibits an organization from restricting information that a health care provider may give to a patient. Requires that an adequate network of providers be maintained. Creates the Utilization Review Law. Sets forth standards and procedures for determining whether services are covered. Establishes timeframes for making utilization review determinations. Sets forth requirements for appeals from adverse decisions. LRB9000248JSmb HB0626 Engrossed LRB9000248JSmb 1 AN ACT relating to the delivery of health care services. 2 Be it enacted by the People of the State of Illinois, 3 represented in the General Assembly: 4 Section 1. Short title. This Act may be cited as the 5 Managed Care Reform Act. 6 Section 5. Definitions. For purposes of this Act, the 7 following words shall have the meanings provided in this 8 Section, unless otherwise indicated: 9 "Adverse determination" means a determination by a 10 utilization review agent that an admission, extension of a 11 stay, or other health care service has been reviewed and, 12 based on the information provided, is not medically 13 necessary. 14 "Clinical peer reviewer" or "clinical personnel" means: 15 (1) in the case of physician reviewers, a State 16 licensed physician who is of the same category in the 17 same or similar specialty as the health care provider who 18 typically manages the medical condition, procedure or 19 treatment under review; or 20 (2) in the case of non-physician reviewers, a State 21 licensed or registered health care professional who is 22 in the same profession and same or similar specialty 23 as the health care provider who typically manages the 24 medical condition, procedure, or treatment under review. 25 Nothing herein shall be construed to change any 26 statutorily defined scope of practice. 27 "Culturally and linguistically competent care" means that 28 a managed care plan has staff and procedures in place to 29 provide all covered services and policy procedures in 30 English, Spanish, and any other language spoken as a primary 31 language by 5% or more of its enrollees. HB0626 Engrossed -2- LRB9000248JSmb 1 "Degenerative or disabling condition or disease" means a 2 condition or disease that is permanent or of indefinite 3 duration, that is likely to become worse or more advanced 4 over time, and that substantially impairs a major life 5 function. 6 "Department" means the Department of Public Health. 7 "Director" means the Director of Public Health. 8 "Emergency medical screening examination" means a medical 9 screening examination and evaluation by a physician or, to 10 the extent permitted by applicable laws, by other appropriate 11 personnel under the supervision of a physician to determine 12 whether the need for emergency services exists. 13 "Emergency services" means the provision of health care 14 services for sudden and, at the time, unexpected onset of a 15 health condition that would lead a prudent layperson to 16 believe that failure to receive immediate medical attention 17 would result in serious impairment to bodily function or 18 serious dysfunction of any body organ or part or would place 19 the person's health in serious jeopardy. 20 "Enrollee" means a person enrolled in a managed care 21 plan. 22 "Health care professional" means a physician, registered 23 professional nurse, or other person appropriately licensed or 24 registered pursuant to the laws of this State to provide 25 health care services. 26 "Health care provider" means a health care professional, 27 hospital, facility, or other person appropriately licensed or 28 otherwise authorized to furnish health care services or 29 arrange for the delivery of health care services in this 30 State. 31 "Health care services" means services included in the (i) 32 furnishing of medical care, (ii) hospitalization incident to 33 the furnishing of medical care, and (iii) furnishing of 34 services, including pharmaceuticals, for the purpose of HB0626 Engrossed -3- LRB9000248JSmb 1 preventing, alleviating, curing, or healing human illness or 2 injury to an individual. 3 "Informal policy or procedure" means a nonwritten policy 4 or procedure, the existence of which may be proven by an 5 admission of an authorized agent of a managed care plan or 6 statistical evidence supported by anecdotal evidence. 7 "Life threatening condition or disease" means any 8 condition, illness, or injury that, in the opinion of a 9 licensed physician, (i) may directly lead to a patient's 10 death, (ii) results in a period of unconsciousness which is 11 indeterminate at the present, or (iii) imposes severe pain or 12 an inhumane burden on the patient. 13 "Managed care plan" means a plan that establishes, 14 operates, or maintains a network of health care providers 15 that have entered into agreements with the plan to provide 16 health care services to enrollees where the plan has the 17 obligation to the enrollee to arrange for the provision of or 18 pay for services through: 19 (1) organizational arrangements for ongoing quality 20 assurance, utilization review programs, or dispute 21 resolution; or 22 (2) financial incentives for persons enrolled in 23 the plan to use the participating providers and 24 procedures covered by the plan. 25 A managed care plan may be established or operated by any 26 entity including, but not necessarily limited to, a licensed 27 insurance company, hospital or medical service plan, health 28 maintenance organization, limited health service 29 organization, preferred provider organization, third party 30 administrator, independent practice association, or employer 31 or employee organization. 32 For purposes of this definition, "managed care plan" 33 shall not include the following: 34 (1) strict indemnity health insurance policies or HB0626 Engrossed -4- LRB9000248JSmb 1 plans issued by an insurer that does not require approval 2 of a primary care provider or other similar coordinator 3 to access health care services; and 4 (2) managed care plans that offer only dental or 5 vision coverage. 6 "Post-stabilization services" means those health care 7 services determined by a treating provider to be promptly and 8 medically necessary following stabilization of an emergency 9 condition. 10 "Primary care provider" means a physician licensed to 11 practice medicine in all its branches who provides a broad 12 range of personal medical care (preventive, diagnostic, 13 curative, counseling, or rehabilitative) in a comprehensive 14 and coordinated manner over time for a managed care plan. 15 "Specialist" means a health care professional who 16 concentrates practice in a recognized specialty field of 17 care. 18 "Speciality care center" means only a center that is 19 accredited by an agency of the State or federal government or 20 by a voluntary national health organization as having special 21 expertise in treating the life-threatening disease or 22 condition or degenerative or disabling disease or condition 23 for which it is accredited. 24 "Utilization review" means the review, undertaken by a 25 entity other than the managed care plan itself, to determine 26 whether health care services that have been provided, are 27 being provided or are proposed to be provided to an 28 individual by a managed care plan, whether undertaken prior 29 to, concurrent with, or subsequent to the delivery of 30 such services are medically necessary. For the purposes 31 of this Act, none of the following shall be considered 32 utilization review: 33 (1) denials based on failure to obtain health care 34 services from a designated or approved health care HB0626 Engrossed -5- LRB9000248JSmb 1 provider as required under an enrollee's contract; 2 (2) the review of the appropriateness of the 3 application of a particular coding to a patient, 4 including the assignment of diagnosis and procedure; 5 (3) any issues relating to the determination of 6 the amount or extent of payment other than determinations 7 to deny payment based on an adverse determination; and 8 (4) any determination of any coverage issues other 9 than whether health care services are or were medically 10 necessary. 11 "Utilization review agent" means any company, 12 organization, or other entity performing utilization review, 13 except: 14 (1) an agency of the State or federal government; 15 (2) an agent acting on behalf of the federal 16 government, but only to the extent that the agent is 17 providing services to the federal government; 18 (3) an agent acting on behalf of the State and 19 local government for services provided pursuant to 20 Title XIX of the federal Social Security Act, but only to 21 the extent that the agent is providing services to the 22 State or local government; 23 (4) a hospital's internal quality assurance program 24 except if associated with a health care financing 25 mechanism. 26 "Utilization review plan" means: 27 (1) a description of the process for developing the 28 written clinical review criteria; 29 (2) a description of the types of written clinical 30 information which the plan might consider in its clinical 31 review including, but not limited to, a set of specific 32 written clinical review criteria; 33 (3) a description of practice guidelines and 34 standards used by a utilization review agent in making a HB0626 Engrossed -6- LRB9000248JSmb 1 determination of medical necessity; 2 (4) the procedures for scheduled review and 3 evaluation of the written clinical review criteria; and 4 (5) a description of the qualifications and 5 experience of the health care professionals who 6 developed the criteria, who are responsible for periodic 7 evaluation of the criteria and of the health care 8 professionals or others who use the written clinical 9 review criteria in the process of utilization review. 10 Section 10. Disclosure of information. 11 (a) An enrollee, and upon request a prospective enrollee 12 prior to enrollment, shall be supplied with written 13 disclosure information, containing at least the information 14 specified in this Section, if applicable, which may be 15 incorporated into the member handbook or the enrollee 16 contract or certificate. All written descriptions shall be 17 in readable and understandable format, consistent with 18 standards developed for supplemental insurance coverage under 19 Title XVIII of the Social Security Act. The Department shall 20 promulgate rules to standardize this format so that potential 21 members can compare the attributes of the various managed 22 care entities. In the event of any inconsistency between any 23 separate written disclosure statement and the enrollee 24 contract or certificate, the terms of the enrollee 25 contract or certificate shall be controlling. The 26 information to be disclosed shall include, at a minimum, 27 all of the following: 28 (1) A description of coverage provisions, health 29 care benefits, benefit maximums, including benefit 30 limitations, and exclusions of coverage, including the 31 definition of medical necessity used in determining 32 whether benefits will be covered. 33 (2) A description of all prior authorization or HB0626 Engrossed -7- LRB9000248JSmb 1 other requirements for treatments, pharmaceuticals, and 2 services. 3 (3) A description of utilization review policies 4 and procedures used by the managed care plan, 5 including the circumstances under which utilization 6 review will be undertaken, the toll-free telephone 7 number of the utilization review agent, the timeframes 8 under which utilization review decisions must be made for 9 prospective, retrospective, and concurrent decisions, 10 the right to reconsideration, the right to an appeal, 11 including the expedited and standard appeals processes 12 and the timeframes for those appeals, the right to 13 designate a representative, a notice that all denials of 14 claims will be made by clinical personnel, and that 15 all notices of denials will include information about the 16 basis of the decision and further appeal rights, if any. 17 (4) A description prepared annually of the types of 18 methodologies the managed care plan uses to reimburse 19 providers specifying the type of methodology that is 20 used to reimburse particular types of providers or 21 reimburse for the provision of particular types of 22 services, provided, however, that nothing in this item 23 should be construed to require disclosure of individual 24 contracts or the specific details of any financial 25 arrangement between a managed care plan and a health care 26 provider. 27 (5) An explanation of a enrollee's financial 28 responsibility for payment of premiums, coinsurance, 29 co-payments, deductibles, and any other charges, annual 30 limits on an enrollee's financial responsibility, caps 31 on payments for covered services and financial 32 responsibility for non-covered health care procedures, 33 treatments, or services provided within the managed 34 care plan. HB0626 Engrossed -8- LRB9000248JSmb 1 (6) An explanation of an enrollee's financial 2 responsibility for payment when services are provided by 3 a health care provider who is not part of the managed 4 care plan or by any provider without required 5 authorization or when a procedure, treatment, or service 6 is not a covered health care benefit. 7 (7) A description of the grievance procedures to 8 be used to resolve disputes between a managed care plan 9 and an enrollee, including the right to file a 10 grievance regarding any dispute between an enrollee and a 11 managed care plan, the right to file a grievance 12 orally when the dispute is about referrals or covered 13 benefits, the toll-free telephone number that enrollees 14 may use to file an oral grievance, the timeframes and 15 circumstances for expedited and standard grievances, the 16 right to appeal a grievance determination and the 17 procedures for filing the appeal, the timeframes and 18 circumstances for expedited and standard appeals, the 19 right to designate a representative, a notice that all 20 disputes involving clinical decisions will be made by 21 clinical personnel, and that all notices of determination 22 will include information about the basis of the 23 decision and further appeal rights, if any. 24 (8) A description of the procedure for providing 25 care and coverage 24 hours a day for emergency services. 26 The description shall include the definition of 27 emergency services, notice that emergency services are 28 not subject to prior approval, and an explanation of 29 the enrollee's financial and other responsibilities 30 regarding obtaining those services, including when 31 those services are received outside the managed care 32 plan's service area. 33 (9) A description of procedures for enrollees to 34 select and access the managed care plan's primary and HB0626 Engrossed -9- LRB9000248JSmb 1 specialty care providers, including notice of how to 2 determine whether a participating provider is accepting 3 new patients. 4 (10) A description of the procedures for changing 5 primary and specialty care providers within the managed 6 care plan. 7 (11) Notice that an enrollee may obtain a referral 8 to a health care provider outside of the managed care 9 plan's network or panel when the managed care plan 10 does not have a health care provider with appropriate 11 training and experience in the network or panel to meet 12 the particular health care needs of the enrollee and 13 the procedure by which the enrollee can obtain the 14 referral. 15 (12) Notice that an enrollee with a condition 16 that requires ongoing care from a specialist may 17 request a standing referral to the specialist and 18 the procedure for requesting and obtaining a standing 19 referral. 20 (13) Notice that an enrollee with (i) a 21 life-threatening condition or disease or (ii) a 22 degenerative or disabling condition or disease, either of 23 which requires specialized medical care over a prolonged 24 period of time, may request a specialist responsible for 25 providing or coordinating the enrollee's medical care and 26 the procedure for requesting and obtaining the 27 specialist. 28 (14) A description of the mechanisms by which 29 enrollees may participate in the development of the 30 policies of the managed care plan. 31 (15) A description of how the managed care plan 32 addresses the needs of non-English speaking enrollees. 33 (16) Notice of all appropriate mailing addresses 34 and telephone numbers to be utilized by enrollees HB0626 Engrossed -10- LRB9000248JSmb 1 seeking information or authorization. 2 (17) A listing by specialty, which may be in a 3 separate document that is updated annually, of the name, 4 address, and telephone number of all participating 5 providers, including facilities, and, in addition, in the 6 case of physicians, category of license and board 7 certification, if applicable. 8 (b) Upon request of an enrollee or prospective enrollee, 9 a managed care plan shall do all of the following: 10 (1) Provide a list of the names, business 11 addresses, and official positions of the members of the 12 board of directors, officers, controlling persons, 13 owners, and partners of the managed care plan. 14 (2) Provide a copy of the most recent annual 15 certified financial statement of the managed care plan, 16 including a balance sheet and summary of receipts and 17 disbursements and the ratio of (i) premium dollars going 18 to administrative expenses to (ii) premium dollars going 19 to direct care, prepared by a certified public 20 accountant. The Department shall promulgate rules to 21 standardize the information that must be contained in the 22 statement and the statement's format. 23 (3) Provide information relating to consumer 24 complaints compiled in accordance with subsection (b) of 25 Section 30 of this Act and the rules promulgated under 26 this Act. 27 (4) Provide the procedures for protecting the 28 confidentiality of medical records and other enrollee 29 information. 30 (5) Allow enrollees and prospective enrollees to 31 inspect drug formularies used by the managed care plan 32 and disclose whether individual drugs are included or 33 excluded from coverage and whether a drug requires prior 34 authorization. An enrollee or prospective enrollee may HB0626 Engrossed -11- LRB9000248JSmb 1 seek information as to the inclusion or exclusion of a 2 specific drug. A managed care plan need only release the 3 information if the enrollee or prospective enrollee or 4 his or her dependent needs, used, or may need or use the 5 drug. 6 (6) Provide a written description of the 7 organizational arrangements and ongoing procedures of 8 the managed care plan's quality assurance program. 9 (7) Provide a description of the procedures 10 followed by the managed care plan in making decisions 11 about the experimental or investigational nature of 12 individual drugs, medical devices, or treatments in 13 clinical trials. 14 (8) Provide individual health care professional 15 affiliations with participating hospitals, if any. 16 (9) Upon written request, provide specific 17 written clinical review criteria relating to a 18 particular condition or disease and, where appropriate, 19 other clinical information that the managed care plan 20 might consider in its utilization review; the managed 21 care plan may include with the information a description 22 of how it will be used in the utilization review 23 process. An enrollee or prospective enrollee may seek 24 information as to specific clinical review criteria. A 25 managed care plan need only release the information if 26 the enrollee or prospective enrollee or his or her 27 dependent has, may have, or is at risk of contracting a 28 particular condition or disease. 29 (10) Provide the written application procedures and 30 minimum qualification requirements for health care 31 providers to be considered by the managed care plan. 32 (11) Disclose other information as required by 33 the Director. 34 (12) To the extent the information provided under HB0626 Engrossed -12- LRB9000248JSmb 1 item (5) or (9) of this subsection is proprietary to the 2 managed care plan, the enrollee or prospective enrollee 3 shall only use the information for the purposes of 4 assisting the enrollee or prospective enrollee in 5 evaluating the covered services provided by the managed 6 care plan. Any misuse of proprietary data is prohibited, 7 provided that the managed care plan has labeled or 8 identified the data as proprietary. 9 (c) Nothing in this Section shall prevent a managed care 10 plan from changing or updating the materials that are made 11 available to enrollees or prospective enrollees. 12 (d) If a primary care provider ceases participation in 13 the managed care plan, the managed care plan shall provide 14 written notice within 15 business days from the date that the 15 managed care plan becomes aware of the change in status to 16 each of the enrollees who have chosen the provider as 17 their primary care provider. If an enrollee is in an 18 ongoing course of treatment with any other participating 19 provider who becomes unavailable to continue to provide 20 services to the enrollee and the managed care plan is aware 21 of the ongoing course of treatment, the managed care plan 22 shall provide written notice within 15 business days from 23 the date that the managed care plan becomes aware of the 24 unavailability to the enrollee. The notice shall also 25 describe the procedures for continuing care. 26 (e) A managed care plan offering to indemnify enrollees 27 for non-participating provider services shall file a report 28 with the Director twice a year showing the percentage 29 utilization for the preceding 6 month period of 30 non-participating provider services in such form and 31 providing such other information as the Director shall 32 prescribe. 33 (f) The written information disclosure requirements of 34 this Section may be met by disclosure to one enrollee in a HB0626 Engrossed -13- LRB9000248JSmb 1 household. 2 Section 15. General grievance procedure. 3 (a) A managed care plan shall establish and maintain a 4 grievance procedure, as described in this Act. Compliance 5 with this Act's grievance procedures shall satisfy a managed 6 care plan's obligation to provide grievance procedures under 7 any other State law or rules. 8 A copy of the grievance procedures, including all forms 9 used to process a grievance, shall be filed with the 10 Director. Any subsequent material modifications to the 11 documents also shall be filed. In addition, a managed care 12 plan shall file annually with the Director a certificate of 13 compliance stating that the managed care plan has established 14 and maintains, for each of its plans, grievance procedures 15 that fully comply with the provisions of this Act. The 16 Director has authority to disapprove a filing that fails to 17 comply with this Act or applicable rules. 18 (b) A managed care plan shall provide written notice of 19 the grievance procedure to all enrollees in the member 20 handbook and to an enrollee at any time that the managed care 21 plan denies access to a referral or determines that a 22 requested benefit is not covered pursuant to the terms of the 23 contract. In the event that a managed care plan denies a 24 service as an adverse determination, the managed care plan 25 shall inform the enrollee or the enrollee's designee of 26 the appeal rights under this Act. 27 The notice to an enrollee describing the grievance 28 process shall explain the process for filing a grievance 29 with the managed care plan, the timeframes within which a 30 grievance determination must be made, and the right of an 31 enrollee to designate a representative to file a grievance on 32 behalf of the enrollee. Information required to be disclosed 33 or provided under this Section must be provided in a HB0626 Engrossed -14- LRB9000248JSmb 1 reasonable and understandable format. 2 The managed care plan shall assure that the grievance 3 procedure is reasonably accessible to those who do not speak 4 English. 5 (c) A managed care plan shall not retaliate or take 6 any discriminatory action against an enrollee because an 7 enrollee has filed a grievance or appeal. 8 Section 20. First level grievance review. 9 (a) The managed care plan may require an enrollee to 10 file a grievance in writing, by letter or by a grievance 11 form which shall be made available by the managed care plan, 12 however, an enrollee must be allowed to submit an oral 13 grievance in connection with (i) a denial of, or failure to 14 pay for, a referral or service or (ii) a determination as to 15 whether a benefit is covered pursuant to the terms of the 16 enrollee's contract. In connection with the submission of 17 an oral grievance, a managed care plan shall, within 24 18 hours, reduce the complaint to writing and give the enrollee 19 written acknowledgment of the grievance prepared by the 20 managed care plan summarizing the nature of the grievance 21 and requesting any information that the enrollee needs to 22 provide before the grievance can be processed. The 23 acknowledgment shall be mailed within the 24-hour period 24 to the enrollee, who shall sign and return the 25 acknowledgment, with any amendments and requested 26 information, in order to initiate the grievance. The 27 grievance acknowledgment shall prominently state that the 28 enrollee must sign and return the acknowledgment to 29 initiate the grievance. A managed care plan may elect not to 30 require a signed acknowledgment when no additional 31 information is necessary to process the grievance, and an 32 oral grievance shall be initiated at the time of the 33 telephone call. HB0626 Engrossed -15- LRB9000248JSmb 1 Except as authorized in this subsection, a managed care 2 plan shall designate personnel to accept the filing of an 3 enrollee's grievance by toll-free telephone no less than 4 40 hours per week during normal business hours and shall 5 have a telephone system available to take calls during other 6 than normal business hours and shall respond to all such 7 calls no later than the next business day after the call was 8 recorded. In the case of grievances subject to item (i) of 9 subsection (b) of this Section, telephone access must be 10 available on a 24 hour a day, 7 day a week basis. 11 (b) Within 48 hours of receipt of a written grievance, 12 the managed care plan shall provide written acknowledgment 13 of the grievance, including the name, address, 14 qualifying credentials, and telephone number of the 15 individuals or department designated by the managed care plan 16 to respond to the grievance. All grievances shall be 17 resolved in an expeditious manner, and in any event, no more 18 than (i) 24 hours after the receipt of all necessary 19 information when a delay would significantly increase the 20 risk to an enrollee's health or when extended health care 21 services, procedures, or treatments for an enrollee 22 undergoing a course of treatment prescribed by a health care 23 provider are at issue, (ii) 15 days after the receipt of all 24 necessary information in the case of requests for referrals 25 or determinations concerning whether a requested benefit 26 is covered pursuant to the contract, and (iii) 30 days after 27 the receipt of all necessary information in all other 28 instances. 29 (c) The managed care plan shall designate one or more 30 qualified personnel to review the grievance. When the 31 grievance pertains to clinical matters, the personnel shall 32 include, but not be limited to, one or more appropriately 33 licensed or registered health care professionals. 34 (d) The notice of a determination of the grievance HB0626 Engrossed -16- LRB9000248JSmb 1 shall be made in writing to the enrollee or to the enrollee's 2 designee. In the case of a determination made in conformance 3 with item (i) of subsection (b) of this Section, notice 4 shall be made by telephone directly to the enrollee with 5 written notice to follow within 2 business days. 6 (e) The notice of a determination shall include (i) 7 clear and detailed reasons for the determination, including 8 any contract basis for the determination, and the evidence 9 relied upon in making that determination, (ii) in cases where 10 the determination has a clinical basis, the clinical 11 rationale for the determination, and (iii) the procedures for 12 the filing of an appeal of the determination, including a 13 form for the filing of an appeal. 14 Section 25. Second level grievance review. 15 (a) A managed care plan shall establish a second level 16 grievance review process to give those enrollees who are 17 dissatisfied with the first level grievance review decision 18 the option to request a second level review, at which the 19 enrollee shall have the right to appear in person before 20 authorized individuals designated to respond to the appeal. 21 (b) An enrollee or an enrollee's designee shall 22 have not less than 60 days after receipt of notice of the 23 grievance determination to file a written appeal, which may 24 be submitted by letter or by a form supplied by the managed 25 care plan. The enrollee shall indicate in his or her written 26 appeal whether he or she wants the right to appear in person 27 before the person or panel designated to respond to the 28 appeal. 29 (c) Within 48 hours of receipt of the second level 30 grievance review, the managed care plan shall provide written 31 acknowledgment of the appeal, including the name, address, 32 qualifying credentials, and telephone number of the 33 individual designated by the managed care plan to respond HB0626 Engrossed -17- LRB9000248JSmb 1 to the appeal and what additional information, if any, must 2 be provided in order for the managed care plan to render a 3 decision. 4 (d) The determination of a second level grievance review 5 on a clinical matter must be made by personnel qualified 6 to review the appeal, including appropriately licensed or 7 registered health care professionals who did not make 8 the initial determination, a majority of whom must be 9 clinical peer reviewers. The determination of a second 10 level grievance review on a matter that is not clinical shall 11 be made by qualified personnel at a higher level than the 12 personnel who made the initial grievance determination. 13 (e) The managed care plan shall seek to resolve all 14 second level grievance reviews in the most expeditious manner 15 and shall make a determination and provide notice no more 16 than (i) 24 hours after the receipt of all necessary 17 information when a delay would significantly increase the 18 risk to an enrollee's health or when extended health care 19 services, procedures, or treatments for an enrollee 20 undergoing a course of treatment prescribed by a health care 21 provider are at issue and (ii) 30 business days after the 22 receipt of all necessary information in all other instances. 23 (f) The notice of a determination on a second level 24 grievance review shall include (i) the detailed reasons for 25 the determination, including any contract basis for the 26 determination and the evidence relied upon in making the 27 determination and (ii) in cases where the determination has a 28 clinical basis, the clinical rationale for the 29 determination. 30 (g) If an enrollee has requested the opportunity to 31 appear in person before the authorized representatives of the 32 managed care plan designated to respond to the appeal, the 33 review panel shall schedule and hold a review meeting within 34 30 days of receiving a request from an enrollee for a second HB0626 Engrossed -18- LRB9000248JSmb 1 level review with a right to appear. The review meeting 2 shall be held during regular business hours at a location 3 reasonably accessible to the enrollee. The enrollee shall be 4 notified in writing at least 14 days in advance of the review 5 date. 6 Upon the request of an enrollee, a managed care plan 7 shall provide to the enrollee all relevant information that 8 is not confidential or privileged. 9 An enrollee has the right to: 10 (1) attend the second level review; 11 (2) present his or her case to the review panel; 12 (3) submit supporting material both before and at 13 the review meeting; 14 (4) ask questions of any representative of the 15 managed care plan; and 16 (5) be assisted or represented by persons of his or 17 her choice. 18 The notice shall advise the enrollee of the rights 19 specified in this subsection. 20 If the managed care plan desires to have an attorney 21 present to represent its interests, it shall notify the 22 enrollee at least 14 days in advance of the review that an 23 attorney will be present and that the enrollee may wish to 24 obtain legal representation of his or her own. 25 Section 30. Grievance register and reporting 26 requirements. 27 (a) A managed care plan shall maintain a register 28 consisting of a written record of all complaints initiated 29 during the past 3 years. The register shall be maintained in 30 a manner that is reasonably clear and accessible to the 31 Director. The register shall include at a minimum the 32 following: 33 (1) the name of the enrollee; HB0626 Engrossed -19- LRB9000248JSmb 1 (2) a description of the reason for the complaint; 2 (3) the dates when first level and second level 3 review were requested and completed; 4 (4) a copy of the written decision rendered at each 5 level of review; 6 (5) if required time limits were exceeded, an 7 explanation of why they were exceeded and a copy of the 8 enrollee's consent to an extension of time; 9 (6) whether expedited review was requested and the 10 response to the request; 11 (7) whether the complaint resulted in litigation 12 and the result of the litigation. 13 (b) A managed care plan shall report annually to the 14 Department the numbers, and related information where 15 indicated, for the following: 16 (1) covered lives; 17 (2) total complaints initiated; 18 (3) total complaints involving medical necessity or 19 appropriateness; 20 (4) complaints involving termination or reduction 21 of inpatient hospital services; 22 (5) complaints involving termination or reduction 23 of other health care services; 24 (6) complaints involving denial of health care 25 services where the enrollee had not received the services 26 at the time the complaint was initiated; 27 (7) complaints involving payment for health care 28 services that the enrollee had already received at the 29 time of initiating the complaint; 30 (8) complaints resolved at each level of review and 31 how they were resolved; 32 (9) complaints where expedited review was provided 33 because adherence to regular time limits would have 34 jeopardized the enrollee's life, health, or ability to HB0626 Engrossed -20- LRB9000248JSmb 1 regain maximum function; and 2 (10) complaints that resulted in litigation and the 3 outcome of the litigation. 4 The Department shall promulgate rules regarding the 5 format of the report, the timing of the report, and other 6 matters related to the report. 7 Section 35. External independent review. 8 (a) If an enrollee's or enrollee's designee's request 9 for a covered service or claim for a covered service is 10 denied under the grievance review under Section 25 because 11 the service is not viewed as medically necessary, the 12 enrollee may initiate an external independent review. 13 (b) Within 30 days after the enrollee receives written 14 notice of such an adverse decision made under the second 15 level grievance review procedures of Section 25, if the 16 enrollee decides to initiate an external independent review, 17 the enrollee shall send to the managed care plan a written 18 request for an external independent review, including any 19 material justification or documentation to support the 20 enrollee's request for the covered service or claim for a 21 covered service. 22 (c) Within 30 days after the managed care plan receives 23 a request for an external independent review from an 24 enrollee, the managed care plan shall: 25 (1) provide a mechanism for jointly selecting an 26 external independent reviewer by the enrollee, primary 27 care physician, and managed care plan; and 28 (2) forward to the independent reviewer all medical 29 records and supporting documentation pertaining to the 30 case, a summary description of the applicable issues 31 including a statement of the managed care plan's 32 decision, and the criteria used and the clinical reasons 33 for that decision. HB0626 Engrossed -21- LRB9000248JSmb 1 (d) Within 5 days of receipt of all necessary 2 information, the independent reviewer or reviewers shall 3 evaluate and analyze the case and render a decision that is 4 based on whether or not the service or claim for the service 5 is medically necessary. The decision by the independent 6 reviewer or reviewers is final. 7 (e) Pursuant to subsection (c) of this Section, an 8 external independent reviewer shall: 9 (1) have no direct financial interest in or 10 connection to the case; 11 (2) be State licensed physicians, who are board 12 certified or board eligible by the appropriate American 13 Medical Specialty Board, if applicable, and who are in 14 the same or similar scope of practice as a physician who 15 typically manages the medical condition, procedure, or 16 treatment under review; and 17 (3) have not been informed of the specific identity 18 of the enrollee or the enrollee's treating provider. 19 (f) If an appropriate reviewer pursuant to subsection 20 (e) of this Section for a particular case is not on the list 21 established by the Director, the parties shall choose a 22 reviewer who is mutually acceptable. 23 Section 40. Independent reviewers. 24 (a) From information filed with the Director on or 25 before March 1 of each year, the Director shall compile a 26 list of external independent reviewers and organizations that 27 represent external independent reviewers from lists provided 28 by managed care plans and by any State and county public 29 health department and State medical associations that wish to 30 submit a list to the Director. The Director may consult with 31 other persons about the suitability of any reviewer or any 32 potential reviewer. The Director shall annually review the 33 list and add and remove names as appropriate. On or before HB0626 Engrossed -22- LRB9000248JSmb 1 June 1 of each year, the Director shall publish the list in 2 the Illinois Register. 3 (b) The managed care plan shall be solely responsible 4 for paying the fees of the external independent reviewer who 5 is selected to perform the review. 6 (c) An external independent reviewer who acts in good 7 faith shall have immunity from any civil or criminal 8 liability or professional discipline as a result of acts or 9 omissions with respect to any external independent review, 10 unless the acts or omissions constitute wilful and wanton 11 misconduct. For purposes of any proceeding, the good faith 12 of the person participating shall be presumed. 13 (d) The Director's decision to add a name to or remove a 14 name from the list of independent reviewers pursuant to 15 subsection (a) is not subject to administrative appeal or 16 judicial review. 17 Section 45. Health care professional applications and 18 terminations. 19 (a) A managed care plan shall, upon request, make 20 available and disclose to health care professionals written 21 application procedures and minimum qualification 22 requirements that a health care professional must meet in 23 order to be considered by the managed care plan. The 24 managed care plan shall consult with appropriately qualified 25 health care professionals in developing its qualification 26 requirements. 27 (b) A managed care plan may not terminate a contract of 28 employment or refuse to renew a contract on the basis of any 29 action protected under Section 50 of this Act or solely 30 because a health care professional has: 31 (1) filed a complaint against the managed care 32 plan; 33 (2) appealed a decision of the managed care plan; HB0626 Engrossed -23- LRB9000248JSmb 1 or 2 (3) requested a hearing pursuant to this Section. 3 (c) A managed care plan shall provide to a health care 4 professional, in writing, the reasons for the contract 5 termination or non-renewal. 6 (d) A managed care plan shall provide an opportunity 7 for a hearing to any health care professional terminated by 8 the managed care plan, or non-renewed if the health care 9 professional has had a contract or contracts with the managed 10 care plan for at least 24 of the past 36 months. 11 (e) After the notice provided pursuant to subsection 12 (c), the health care professional shall have 21 days to 13 request a hearing, and the hearing must be held within 15 14 days after receipt of the request for a hearing. The hearing 15 shall be held before a panel appointed by the managed care 16 plan. 17 The hearing panel shall be composed of 5 individuals, the 18 majority of whom shall be clinical peer reviewers and, to the 19 extent possible, in the same discipline and the same or 20 similar specialty as the health care professional under 21 review. 22 The hearing panel shall render a written decision on the 23 proposed action within 14 business days. The decision shall 24 be one of the following: 25 (1) reinstatement of the health care professional 26 by the managed care plan; 27 (2) provisional reinstatement subject to 28 conditions set forth by the panel; or 29 (3) termination of the health care professional. 30 The decision of the hearing panel shall be final. 31 A decision by the hearing panel to terminate a health 32 care professional shall be effective not less than 15 days 33 after the receipt by the health care professional of the 34 hearing panel's decision. HB0626 Engrossed -24- LRB9000248JSmb 1 A hearing under this subsection shall provide the health 2 care professional in question with the right to examine 3 pertinent information, to present witnesses, and to ask 4 questions of an authorized representative of the plan. 5 (f) A managed care plan may terminate or decline to 6 renew a health care professional, without a prior hearing, in 7 cases involving imminent harm to patient care, a 8 determination of intentional falsification of reports to the 9 plan or a final disciplinary action by a state licensing 10 board or other governmental agency that impairs the health 11 care professional's ability to practice. A professional 12 terminated for one of the these reasons shall be given 13 written notice to that effect. Within 21 days after the 14 termination, a health care professional terminated because of 15 imminent harm to patient care or a determination of 16 intentional falsification of reports to the plan shall 17 receive a hearing. The hearing shall be held before a panel 18 appointed by the managed care plan. The panel shall be 19 composed of 5 individuals the majority of whom shall be 20 clinical peer reviewers and, to the extent possible, in the 21 same discipline and the same or similar specialty as the 22 health care professional under review. The hearing panel 23 shall render a decision on the proposed action within 14 24 days. The panel shall issue a written decision either 25 supporting the termination or ordering the health care 26 professional's reinstatement. The decision of the hearing 27 panel shall be final. 28 If the hearing panel upholds the managed care plan's 29 termination of the health care professional under this 30 subsection, the managed care plan shall forward the decision 31 to the appropriate professional disciplinary agency in 32 accordance with subsection (b) of Section 60. 33 Any hearing under this subsection shall provide the 34 health care professional in question with the right to HB0626 Engrossed -25- LRB9000248JSmb 1 examine pertinent information, to present witnesses, and to 2 ask questions of an authorized representative of the plan. 3 For any hearing under this Section, because the candid 4 and conscientious evaluation of clinical practices is 5 essential to the provision of health care, it is the policy 6 of this State to encourage peer review by health care 7 professionals. Therefore, no managed care plan and no 8 individual who participates in a hearing or who is a member, 9 agent, or employee of a managed care plan shall be liable for 10 criminal or civil damages or professional discipline as a 11 result of the acts, omissions, decisions, or any other 12 conduct, direct or indirect, associated with a hearing panel, 13 except for wilful and wanton misconduct. Nothing in this 14 Section shall relieve any person, health care provider, 15 health care professional, facility, organization, or 16 corporation from liability for his, her, or its own 17 negligence in the performance of his, her, or its duties or 18 arising from treatment of a patient. The hearing panel 19 information shall not be subject to inspection or disclosure 20 except upon formal written request by an authorized 21 representative of a duly authorized State agency or pursuant 22 to a court order issued in a pending action or proceeding. 23 (g) A managed care plan shall develop and implement 24 policies and procedures to ensure that health care 25 professionals are at least annually informed of information 26 maintained by the managed care plan to evaluate the 27 performance or practice of the health care professional. The 28 managed care plan shall consult with health care 29 professionals in developing methodologies to collect and 30 analyze health care professional data. Managed care plans 31 shall provide the information and data and analysis to health 32 care professionals. The information, data, or analysis 33 shall be provided on at least an annual basis in a format 34 appropriate to the nature and amount of data and the volume HB0626 Engrossed -26- LRB9000248JSmb 1 and scope of services provided. Any data used to evaluate 2 the performance or practice of a health care professional 3 shall be measured against stated criteria and a comparable 4 group of health care professionals who use similar treatment 5 modalities and serve a comparable patient population. Upon 6 receipt of the information or data, a health care 7 professional shall be given the opportunity to explain the 8 unique nature of the health care professional's patient 9 population that may have a bearing on the health care 10 professional's data and to work cooperatively with the 11 managed care plan to improve performance. 12 (h) Any contract provision or procedure or informal 13 policy or procedure in violation of this Section violates the 14 public policy of the State of Illinois and is void and 15 unenforceable. 16 Section 50. Prohibitions. 17 (a) No managed care plan shall by contract, written 18 policy or written procedure, or informal policy or procedure 19 prohibit or restrict any health care provider from 20 disclosing to any enrollee, patient, designated 21 representative or, where appropriate, prospective 22 enrollee, (hereinafter collectively referred to as 23 enrollee) any information that the provider deems appropriate 24 regarding: 25 (1) a condition or a course of treatment with an 26 enrollee including the availability of other therapies, 27 consultations, or tests; or 28 (2) the provisions, terms, or requirements of the 29 managed care plan's products as they relate to the 30 enrollee, where applicable. 31 (b) No managed care plan shall by contract, written 32 policy or procedure, or informal policy or procedure prohibit 33 or restrict any health care provider from filing a HB0626 Engrossed -27- LRB9000248JSmb 1 complaint, making a report, or commenting to an appropriate 2 governmental body regarding the policies or practices of the 3 managed care plan that the provider believes may 4 negatively impact upon the quality of, or access to, patient 5 care. 6 (c) No managed care plan shall by contract, written 7 policy or procedure, or informal policy or procedure prohibit 8 or restrict any health care provider from advocating to the 9 managed care plan on behalf of the enrollee for approval or 10 coverage of a particular course of treatment or for the 11 provision of health care services. 12 (d) No contract or agreement between a managed care 13 plan and a health care provider shall contain any clause 14 purporting to transfer to the health care provider by 15 indemnification or otherwise any liability relating to 16 activities, actions, or omissions of the managed care plan 17 as opposed to those of the health care provider. 18 (e) No contract between a managed care plan and a health 19 care provider shall contain any incentive plan that includes 20 specific payment made directly, in any form, to a health care 21 provider as an inducement to deny, reduce, limit, or delay 22 specific, medically necessary and appropriate services 23 provided with respect to a specific enrollee or groups of 24 enrollees with similar medical conditions. Nothing in this 25 Section shall be construed to prohibit contracts that contain 26 incentive plans that involve general payments, such as 27 capitation payments or shared-risk arrangements, that are not 28 tied to specific medical decisions involving specific 29 enrollees or groups of enrollees with similar medical 30 conditions. The payments rendered or to be rendered to 31 health care provider under these arrangements shall be deemed 32 confidential information. 33 (f) No managed care plan shall by contract, written 34 policy or procedure, or informal policy or procedure permit, HB0626 Engrossed -28- LRB9000248JSmb 1 allow, or encourage an individual or entity to dispense a 2 different drug in place of the drug or brand of drug ordered 3 or prescribed without the express permission of the person 4 ordering or prescribing, except this prohibition does not 5 prohibit the interchange of different brands of the same 6 generically equivalent drug product, as provided under 7 Section 3.14 of the Illinois Food, Drug and Cosmetic Act. 8 (g) Any contract provision, written policy or 9 procedure, or informal policy or procedure in violation of 10 this Section violates the public policy of the State of 11 Illinois and is void and unenforceable. 12 Section 55. Network of providers. 13 (a) At least once every 3 years, and upon application 14 for expansion of service area, a managed care plan shall 15 obtain certification from the Director of Public Health that 16 the managed care plan maintains a network of health care 17 providers and facilities adequate to meet the comprehensive 18 health needs of its enrollees and to provide an appropriate 19 choice of providers sufficient to provide the services 20 covered under its enrollee's contracts by determining that: 21 (1) there are a sufficient number of geographically 22 accessible participating providers and facilities; 23 (2) there are opportunities to select from at least 24 3 primary care providers pursuant to travel and 25 distance time standards, providing that these standards 26 account for the conditions of accessing providers in 27 rural areas; and 28 (3) there are sufficient providers in all covered 29 areas of specialty practice to meet the needs of the 30 enrollment population. 31 (b) The following criteria shall be considered by the 32 Director of Public Health at the time of a review: 33 (1) provider-enrollee ratios by specialty; HB0626 Engrossed -29- LRB9000248JSmb 1 (2) primary care provider-enrollee ratios; 2 (3) safe and adequate staffing of health care 3 providers in all participating facilities based on: 4 (A) severity of patient illness and functional 5 capacity; 6 (B) factors affecting the period and quality 7 of patient recovery; and 8 (C) any other factor substantially related to 9 the condition and health care needs of patients; 10 (4) geographic accessibility; 11 (5) the number of grievances filed by enrollees 12 relating to waiting times for appointments, 13 appropriateness of referrals, and other indicators of a 14 managed care plan's capacity; 15 (6) hours of operation; 16 (7) the managed care plan's ability to provide 17 culturally and linguistically competent care to meet the 18 needs of its enrollee population; and 19 (8) the volume of technological and speciality 20 services available to serve the needs of enrollees 21 requiring technologically advanced or specialty care. 22 (c) A managed care plan shall report on an annual basis 23 the number of enrollees and the number of participating 24 providers in the managed care plan. 25 (d) If a managed care plan determines that it does not 26 have a health care provider with appropriate training and 27 experience in its panel or network to meet the particular 28 health care needs of an enrollee, the managed care plan 29 shall make a referral to an appropriate provider, pursuant to 30 a treatment plan approved by the primary care provider, in 31 consultation with the managed care plan, the 32 non-participating provider, and the enrollee or enrollee's 33 designee, at no additional cost to the enrollee beyond what 34 the enrollee would otherwise pay for services received within HB0626 Engrossed -30- LRB9000248JSmb 1 the network. 2 (e) A managed care plan shall have a procedure by which 3 an enrollee who needs ongoing health care services, 4 provided or coordinated by a specialist focused on a specific 5 organ system, disease or condition, shall receive a referral 6 to the specialist. If the primary care provider, after 7 consultation with the medical director or other 8 contractually authorized representative of the managed care 9 plan, determines that a referral is appropriate, the primary 10 care provider shall make such a referral to a specialist. In 11 no event shall a managed care plan be required to permit 12 an enrollee to elect to have a non-participating 13 specialist, except pursuant to the provisions of subsection 14 (d). The referral made under this subsection shall be 15 pursuant to a treatment plan approved by the enrollee or 16 enrollee's designee, the primary care provider, and the 17 specialist in consultation with the managed care plan. The 18 treatment plan shall authorize the specialist to treat the 19 ongoing injury, disease, or condition. It also may limit the 20 number of visits or the period during which visits are 21 authorized and may require the specialists to provide the 22 primary care provider with regular updates on the specialty 23 care provided, as well as all necessary medical information. 24 (f) A managed care plan shall have a procedure by which 25 a new enrollee, upon enrollment, or an enrollee, upon 26 diagnosis, with (i) a life-threatening condition or disease 27 or (ii) a degenerative or disabling condition or disease, 28 either of which requires specialized medical care over a 29 prolonged period of time shall receive a standing referral to 30 a specialist with expertise in treating the life-threatening 31 condition or disease or degenerative or disabling condition 32 or disease who shall be responsible for and capable of 33 providing and coordinating the enrollee's primary and 34 specialty care. If the primary care provider, after HB0626 Engrossed -31- LRB9000248JSmb 1 consultation with the enrollee or enrollee's designee and 2 medical director or other contractually authorized 3 representative of the managed care plan, determines that the 4 enrollee's care would most appropriately be coordinated 5 by a specialist, the primary care provider shall refer, on a 6 standing basis, the enrollee to a specialist. In no event 7 shall a managed care plan be required to permit an enrollee 8 to elect to have a non-participating specialist, except 9 pursuant to the provisions of subsection (d). The 10 specialist shall be permitted to treat the enrollee 11 without a referral from the enrollee's primary care 12 provider and shall be authorized to make such referrals, 13 procedures, tests, and other medical services as the 14 enrollee's primary care provider would otherwise be 15 permitted to provide or authorize including, if 16 appropriate, referral to a specialty care center. If a 17 primary care provider refers an enrollee to a 18 non-participating provider pursuant to the provisions of 19 subsection (d), the standing referral shall be pursuant to a 20 treatment plan approved by the enrollee or enrollee's 21 designee and specialist, in consultation with the managed 22 care plan. Services provided pursuant to the approved 23 treatment plan shall be provided at no additional cost to 24 the enrollee beyond what the enrollee would otherwise pay 25 for services received within the network. 26 (g) If an enrollee's health care provider leaves the 27 managed care plan's network of providers for reasons other 28 than those for which the provider would not be eligible to 29 receive a pre-termination hearing pursuant to subsection (f) 30 of Section 45, the managed care plan shall permit the 31 enrollee to continue an ongoing course of treatment 32 with the enrollee's current health care provider during a 33 transitional period of: 34 (1) up to 90 days from the date of notice to the HB0626 Engrossed -32- LRB9000248JSmb 1 enrollee of the provider's disaffiliation from the 2 managed care plan's network; or 3 (2) if the enrollee has entered the second trimester 4 of pregnancy at the time of the provider's 5 disaffiliation, for a transitional period that 6 includes the provision of post-partum care directly 7 related to the delivery. 8 Transitional care, however, shall be authorized by the 9 managed care plan during the transitional period only if the 10 health care provider agrees (i) to continue to accept 11 reimbursement from the managed care plan at the rates 12 applicable prior to the start of the transitional period 13 as payment in full, (ii) to adhere to the managed care plan's 14 quality assurance requirements and to provide to the managed 15 care plan necessary medical information related to the care, 16 (iii) to otherwise adhere to the managed care plan's 17 policies and procedures including, but not limited to, 18 procedures regarding referrals and obtaining 19 pre-authorization and a treatment plan approved by the 20 primary care provider or specialist in consultation with the 21 managed care plan, and (iv) if the enrollee is a recipient of 22 services under Article V of the Illinois Public Aid Code, the 23 health care provider has not been subject to a final 24 disciplinary action by a state or federal agency for 25 violations of the Medicaid or Medicare program. 26 (h) If a new enrollee whose health care provider is not 27 a member of the managed care plan's provider network enrolls 28 in the managed care plan, the managed care plan shall permit 29 the enrollee to continue an ongoing course of treatment with 30 the enrollee's current health care provider during a 31 transitional period of up to 90 days from the effective 32 date of enrollment, if (i) the enrollee has a 33 life-threatening disease or condition or a degenerative or 34 disabling disease or condition or (ii) the enrollee has HB0626 Engrossed -33- LRB9000248JSmb 1 entered the second trimester of pregnancy at the effective 2 date of enrollment, in which case the transitional period 3 shall include the provision of post-partum care directly 4 related to the delivery. If an enrollee elects to continue 5 to receive payment for care from a health care provider 6 pursuant to this subsection, the care shall be authorized by 7 the managed care plan for the transitional period only if 8 the health care provider agrees (i) to accept reimbursement 9 from the managed care plan at rates established by the 10 managed care plan as payment in full, which rates shall be no 11 more than the level of reimbursement applicable to similar 12 providers within the managed care plan's network for 13 those services, (ii) to adhere to the managed care plan's 14 quality assurance requirements and agrees to provide to the 15 managed care plan necessary medical information related to 16 the care, (iii) to otherwise adhere to the managed care 17 plan's policies and procedures including, but not limited 18 to, procedures regarding referrals and obtaining 19 pre-authorization and a treatment plan approved by the 20 primary care provider or specialist, in consultation with the 21 managed care plan, and (iv) if the enrollee is a recipient of 22 services under Article V of the Illinois Public Aid Code, the 23 health care provider has not been subject to a final 24 disciplinary action by a state or federal agency for 25 violations of the Medicaid or Medicare program. In no 26 event shall this subsection be construed to require a managed 27 care plan to provide coverage for benefits not otherwise 28 covered or to diminish or impair pre-existing condition 29 limitations contained within the enrollee's contract. 30 Section 60. Duty to report. 31 (a) A managed care plan shall report to the 32 appropriate professional disciplinary agency, after 33 compliance and in accordance with the provisions of this HB0626 Engrossed -34- LRB9000248JSmb 1 Section: 2 (1) termination of a health care provider contract 3 for commission of an act or acts that may directly 4 threaten patient care, and not of an administrative 5 nature, or that a person may be mentally or physically 6 disabled in such a manner as to endanger a patient under 7 that person's care; 8 (2) voluntary or involuntary termination of a 9 contract or employment or other affiliation with the 10 managed care plan to avoid the imposition of disciplinary 11 measures. 12 The managed care plan shall only make the report after it 13 has provided the health care professional with a hearing on 14 the matter. (This hearing shall not impair or limit the 15 managed care plan's ability to terminate the professional. 16 Its purpose is solely to ensure that a sufficient basis 17 exists for making the report.) The hearing shall be held 18 before a panel appointed by the managed care plan. The 19 hearing panel shall be composed of 5 persons appointed by the 20 plan, the majority of whom shall be clinical peer reviewers, 21 to the extent possible, in the same discipline and the same 22 specialty as the health care professional under review. The 23 hearing panel shall determine whether the proposed basis for 24 the report is supported by a preponderance of the evidence. 25 The panel shall render its determination within 14 days. If 26 a majority of the panel finds the proposed basis for the 27 report is supported by a preponderance of the evidence, the 28 managed care plan shall make the required report within 21 29 days. 30 Any hearing under this Section shall provide the health 31 care professional in question with the right to examine 32 pertinent information, to present witnesses, and to ask 33 questions of an authorized representative of the plan. 34 If a hearing has been held pursuant to subsection (f) of HB0626 Engrossed -35- LRB9000248JSmb 1 Section 45 and the hearing panel sustained a plan's 2 termination of a health care professional, no additional 3 hearing is required, and the plan shall make the report 4 required under this Section. 5 (b) Reports made pursuant to this Section shall be made 6 in writing to the appropriate professional disciplinary 7 agency. Written reports shall include the name, address, 8 profession, and license number of the individual and a 9 description of the action taken by the managed care plan, 10 including the reason for the action and the date thereof, or 11 the nature of the action or conduct that led to the 12 resignation, termination of contract, or withdrawal, and the 13 date thereof. 14 For any hearing under this Section, because the candid 15 and conscientious evaluation of clinical practices is 16 essential to the provision of health care, it is the policy 17 of this State to encourage peer review by health care 18 professionals. Therefore, no managed care plan and no 19 individual who participates in a hearing or who is a member, 20 agent, or employee of a managed care plan shall be liable for 21 criminal or civil damages or professional discipline as a 22 result of the acts, omissions, decisions, or any other 23 conduct, direct or indirect, associated with a hearing panel, 24 except for wilful and wanton misconduct. Nothing in this 25 Section shall relieve any person, health care provider, 26 health care professional, facility, organization, or 27 corporation from liability for his, her, or its own 28 negligence in the performance of his, her, or its duties or 29 arising from treatment of a patient. The hearing panel 30 information shall not be subject to inspection or disclosure 31 except upon formal written request by an authorized 32 representative of a duly authorized State agency or pursuant 33 to a court order issued in a pending action or proceeding. HB0626 Engrossed -36- LRB9000248JSmb 1 Section 65. Disclosure of information. 2 (a) A health care professional affiliated with a 3 managed care plan shall make available, in written form at 4 his or her office, to his or her patients or prospective 5 patients the following: 6 (1) information related to the health care 7 professional's educational background, experience, 8 training, specialty and board certification, if 9 applicable, number of years in practice, and hospitals 10 where he or she has privileges; 11 (2) information regarding the health care 12 professional's participation in continuing education 13 programs and compliance with any licensure, 14 certification, or registration requirements, if 15 applicable; 16 (3) information regarding the health care 17 professional's participation in clinical performance 18 reviews conducted by the Department, where applicable and 19 available; and 20 (4) the location of the health care professional's 21 primary practice setting and the identification of any 22 translation services available. 23 Section 70. Registration of utilization review agents. 24 (a) A utilization review agent who conducts the practice 25 of utilization review shall biennially register with the 26 Director and report, in a statement subscribed and affirmed 27 as true under the penalties of perjury, the information 28 required pursuant to subsection (b) of this Section. 29 (b) The report shall contain a description of the 30 following: 31 (1) the utilization review plan; 32 (2) a description of the grievance procedures by 33 which an enrollee, the enrollee's designee, or his or her HB0626 Engrossed -37- LRB9000248JSmb 1 health care provider may seek reconsideration of adverse 2 determinations by the utilization review agent in 3 accordance with this Act; 4 (3) procedures by which a decision on a request for 5 utilization review for services requiring 6 pre-authorization shall comply with timeframes 7 established pursuant to this Act; 8 (4) a description of an emergency care policy, 9 consistent with this Act. 10 (5) a description of personnel utilized to conduct 11 utilization review, including a description of the 12 circumstances under which utilization review may be 13 conducted by: 14 (A) administrative personnel, 15 (B) health care professionals who are not 16 clinical peer reviewers, and 17 (C) clinical peer reviewers; 18 (6) a description of the mechanisms employed to 19 assure that administrative personnel are trained in the 20 principles and procedures of intake screening and data 21 collection and are appropriately monitored by a 22 licensed health care professional while performing an 23 administrative review; 24 (7) a description of the mechanisms employed to 25 assure that health care professionals conducting 26 utilization review are: 27 (A) appropriately licensed or registered; and 28 (B) trained in the principles, procedures, 29 and standards of the utilization review agent; 30 (8) a description of the mechanisms employed to 31 assure that only a clinical peer reviewer shall render an 32 adverse determination; 33 (9) provisions to ensure that appropriate personnel 34 of the utilization review agent are reasonably accessible HB0626 Engrossed -38- LRB9000248JSmb 1 by toll-free telephone: 2 (A) not less than 40 hours per week during 3 normal business hours, to discuss patient care and 4 allow response to telephone requests, and to ensure 5 that the utilization review agent has a telephone 6 system capable of accepting, recording, or providing 7 instruction to incoming telephone calls during 8 other than normal business hours and to ensure 9 response to accepted or recorded messages not later 10 than the next business day after the date on which 11 the call was received; or 12 (B) notwithstanding the provisions of item (A), 13 in the case of a request submitted pursuant to 14 subsection (c) of Section 80 or an expedited appeal 15 filed pursuant to subsection (b) of Section 85, a 16 response is provided within 24 hours; 17 (10) the policies and procedures to ensure that 18 all applicable State and federal laws to protect the 19 confidentiality of individual medical and treatment 20 records are followed; 21 (11) a copy of the materials to be disclosed to an 22 enrollee or prospective enrollee pursuant to this Act; 23 (12) a description of the mechanisms employed by 24 the utilization review agent to assure that all 25 contractors, subcontractors, subvendors, agents, and 26 employees affiliated by contract or otherwise with such 27 utilization review agent will adhere to the standards and 28 requirements of this Act; and 29 (13) a list of the payors for which the 30 utilization review agent is performing utilization 31 review in this State. 32 (c) Upon receipt of the report, the Director 33 shall issue an acknowledgment of the filing. 34 (d) A registration issued under this Act shall be valid HB0626 Engrossed -39- LRB9000248JSmb 1 for a period of not more than 2 years, and may be renewed for 2 additional periods of not more than 2 years each. 3 Section 75. Utilization review program standards. 4 (a) A utilization review agent shall adhere to 5 utilization review program standards consistent with the 6 provisions of this Act, which shall, at a minimum, include: 7 (1) appointment of a medical director, who is a 8 licensed physician; provided, however, that the 9 utilization review agent may appoint a clinical director 10 when the utilization review performed is for a discrete 11 category of health care service and provided further that 12 the clinical director is a licensed health care 13 professional who typically manages the category of 14 service; responsibilities of the medical director, or, 15 where appropriate, the clinical director, shall 16 include, but not be limited to, the supervision and 17 oversight of the utilization review process; 18 (2) development of written policies and procedures 19 that govern all aspects of the utilization review 20 process and a requirement that a utilization review 21 agent shall maintain and make available to enrollees and 22 health care providers a written description of the 23 procedures, including the procedures to appeal an adverse 24 determination; 25 (3) utilization of written clinical review criteria 26 developed pursuant to a utilization review plan; 27 (4) consistent with the applicable Sections of this 28 Act, establishment of a process for rendering utilization 29 review determinations, which shall, at a minimum, 30 include written procedures to assure that utilization 31 reviews and determinations are conducted within the 32 required timeframes, procedures to notify an enrollee, 33 an enrollee's designee, and an enrollee's health care HB0626 Engrossed -40- LRB9000248JSmb 1 provider of adverse determinations, and the procedures 2 for appeal of adverse determinations, including the 3 establishment of an expedited appeals process for 4 denials of continued inpatient care or when delay would 5 significantly increase the risk to an enrollee's health; 6 (5) establishment of a requirement that 7 appropriate personnel of the utilization review agent are 8 reasonably accessible by toll-free telephone: 9 (A) not less than 40 hours per week during 10 normal business hours to discuss patient care and 11 allow response to telephone requests, and to ensure 12 that the utilization review agent has a telephone 13 system capable of accepting, recording or providing 14 instruction to incoming telephone calls during 15 other than normal business hours and to ensure 16 response to accepted or recorded messages not less 17 than one business day after the date on which the 18 call was received; or 19 (B) in the case of a request submitted 20 pursuant to subsection (c) of Section 80 or an 21 expedited appeal filed pursuant to subsection 22 (b) of Section 85, a response is provided within 24 23 hours; 24 (6) establishment of appropriate policies and 25 procedures to ensure that all applicable State and 26 federal laws to protect the confidentiality of individual 27 medical records are followed; 28 (7) establishment of a requirement that emergency 29 services, as defined in this Act, rendered to an enrollee 30 shall not be subject to prior authorization nor 31 shall reimbursement for those services be denied on 32 retrospective review, except as authorized in this Act. 33 (b) A utilization review agent shall assure adherence to 34 the requirements stated in subsection (a) of this Section by HB0626 Engrossed -41- LRB9000248JSmb 1 all contractors, subcontractors, subvendors, agents, and 2 employees affiliated by contract or otherwise with the 3 utilization review agent. 4 Section 80. Utilization review determinations. 5 (a) Utilization review shall be conducted by: 6 (1) administrative personnel trained in the 7 principles and procedures of intake screening and data 8 collection, provided, however, that administrative 9 personnel shall only perform intake screening, data 10 collection, and non-clinical review functions and shall 11 be supervised by a licensed health care professional; 12 (2) a health care professional who is 13 appropriately trained in the principles, procedures, 14 and standards of the utilization review agent; provided, 15 however, that a health care professional who is not a 16 clinical peer reviewer may not render an adverse 17 determination; and 18 (3) a clinical peer reviewer where the review 19 involves an adverse determination. 20 (b) A utilization review agent shall make a utilization 21 review determination involving health care services that 22 require pre-authorization and provide notice of the 23 determination, as soon as possible, to the enrollee or 24 enrollee's designee and the enrollee's health care provider 25 by telephone upon, and in writing within 2 business days of 26 receipt of the necessary information. 27 (c) A utilization review agent shall make a 28 determination involving continued or extended health care 29 services or additional services for an enrollee 30 undergoing a course of continued treatment prescribed by a 31 health care provider and provide notice of the determination 32 to the enrollee or the enrollee's designee by notice within 33 24 hours to the enrollee's health care provider by telephone HB0626 Engrossed -42- LRB9000248JSmb 1 upon, and in writing within 2 business days after receipt of 2 the necessary information. Notification of continued or 3 extended services shall include the number of extended 4 services approved, the new total of approved services, the 5 date of onset of services, and the next review date. 6 (d) A utilization review agent shall make a utilization 7 review determination involving health care services that have 8 already been delivered, within 30 days of receipt of the 9 necessary information. 10 (e) Notice of an adverse determination made by a 11 utilization review agent shall be given in writing in 12 accordance with the grievance procedures of this Act. The 13 notice shall also specify what, if any, additional 14 necessary information must be provided to, or obtained by, 15 the utilization review agent in order to render a decision on 16 the appeal. 17 (f) In the event that a utilization review agent 18 renders an adverse determination without attempting to 19 discuss the matter with the enrollee's health care 20 provider who specifically recommended the health care 21 service, procedure, or treatment under review, the health 22 care provider shall have the opportunity to request an 23 immediate reconsideration of the adverse determination. 24 Except in cases of retrospective reviews, the 25 reconsideration shall occur in a prompt manner, not to 26 exceed 24 hours after receipt of the necessary information, 27 and shall be conducted by the enrollee's health care 28 provider and the clinical peer reviewer making the initial 29 determination or a designated clinical peer reviewer if the 30 original clinical peer reviewer cannot be available. In 31 the event that the adverse determination is upheld after 32 reconsideration, the utilization review agent shall provide 33 notice as required pursuant to subsection (e) of this 34 Section. Nothing in this Section shall preclude the enrollee HB0626 Engrossed -43- LRB9000248JSmb 1 from initiating an appeal from an adverse determination. 2 Section 85. Appeal of adverse determinations by 3 utilization review agents. 4 (a) An enrollee, the enrollee's designee, and, in 5 connection with retrospective adverse determinations, the 6 enrollee's health care provider may appeal an adverse 7 determination rendered by a utilization review agent pursuant 8 to Sections 15, 20, 25, and 35. 9 (b) A utilization review agent shall establish 10 mechanisms that facilitate resolution of the appeal 11 including, but not limited to, the sharing of information 12 from the enrollee's health care provider and the utilization 13 review agent by telephonic means or by facsimile. The 14 utilization review agent shall provide reasonable access to 15 its clinical peer reviewer in a prompt manner. 16 (c) Appeals shall be reviewed by a clinical peer 17 reviewer other than the clinical peer reviewer who 18 rendered the adverse determination. 19 Section 90. Required and prohibited practices. 20 (a) A utilization review agent shall have written 21 procedures for assuring that patient-specific information 22 obtained during the process of utilization review will be: 23 (1) kept confidential in accordance with applicable 24 State and federal laws; and 25 (2) shared only with the enrollee, the 26 enrollee's designee, the enrollee's health care provider, 27 and those who are authorized by law to receive the 28 information. 29 (b) Summary data shall not be considered confidential 30 if it does not provide information to allow identification of 31 individual patients. 32 (c) Any health care professional who makes HB0626 Engrossed -44- LRB9000248JSmb 1 determinations regarding the medical necessity of health care 2 services during the course of utilization review shall be 3 appropriately licensed or registered. 4 (d) A utilization review agent shall not, with respect 5 to utilization review activities, permit or provide 6 compensation or anything of value to its employees, agents, 7 or contractors based on: 8 (1) either a percentage of the amount by which a 9 claim is reduced for payment or the number of claims or 10 the cost of services for which the person has denied 11 authorization or payment; or 12 (2) any other method that encourages the 13 rendering of an adverse determination. 14 (e) If a health care service has been specifically 15 pre-authorized or approved for an enrollee by a 16 utilization review agent, a utilization review agent shall 17 not, pursuant to retrospective review, revise or modify 18 the specific standards, criteria, or procedures used for 19 the utilization review for procedures, treatment, and 20 services delivered to the enrollee during the same course 21 of treatment. 22 (f) Utilization review shall not be conducted more 23 frequently than is reasonably required to assess whether the 24 health care services under review are medically necessary. 25 The Department may promulgate rules governing the frequency 26 of utilization reviews for managed care plans of differing 27 size and geographic location. 28 (g) When making prospective, concurrent, and 29 retrospective determinations, utilization review agents shall 30 collect only information that is necessary to make the 31 determination and shall not routinely require health care 32 providers to numerically code diagnoses or procedures to 33 be considered for certification, unless required under State 34 or federal Medicare or Medicaid rules or regulations, or HB0626 Engrossed -45- LRB9000248JSmb 1 routinely request copies of medical records of all patients 2 reviewed. During prospective or concurrent review, copies 3 of medical records shall only be required when necessary 4 to verify that the health care services subject to the review 5 are medically necessary. In these cases, only the necessary 6 or relevant sections of the medical record shall be 7 required. A utilization review agent may request copies of 8 partial or complete medical records retrospectively. 9 (h) In no event shall information be obtained from 10 health care providers for the use of the utilization 11 review agent by persons other than health care professionals, 12 medical record technologists, or administrative personnel who 13 have received appropriate training. 14 (i) The utilization review agent shall not undertake 15 utilization review at the site of the provision of health 16 care services unless the utilization review agent: 17 (1) identifies himself or herself by name and the 18 name of his or her organization, including displaying 19 photographic identification that includes the name of 20 the utilization review agent and clearly identifies the 21 individual as representative of the utilization review 22 agent; 23 (2) whenever possible, schedules review at least 24 one business day in advance with the appropriate health 25 care provider; 26 (3) if requested by a health care provider, 27 assures that the on-site review staff register with the 28 appropriate contact person, if available, prior to 29 requesting any clinical information or assistance 30 from the health care provider; and 31 (4) obtains consent from the enrollee or the 32 enrollee's designee before interviewing the patient's 33 family or observing any health care service being 34 provided to the enrollee. HB0626 Engrossed -46- LRB9000248JSmb 1 This subsection does not apply to health care 2 professionals engaged in providing care, case management, or 3 making on-site discharge decisions. 4 (j) A utilization review agent shall not base an adverse 5 determination on a refusal to consent to observing any health 6 care service. 7 (k) A utilization review agent shall not base an adverse 8 determination on lack of reasonable access to a health 9 care provider's medical or treatment records unless the 10 utilization review agent has provided reasonable notice 11 to both the enrollee or the enrollee's designee and the 12 enrollee's health care provider and has complied with all 13 provisions of subsection (i) of this Section. The Department 14 may promulgate rules defining reasonable notice and the time 15 period within which medical and treatment records must be 16 turned over. 17 (l) Neither the utilization review agent nor the entity 18 for which the agent provides utilization review shall take 19 any action with respect to a patient or a health care 20 provider that is intended to penalize the enrollee, the 21 enrollee's designee, or the enrollee's health care provider 22 for, or to discourage the enrollee, the enrollee's designee, 23 or the enrollee's health care provider from, undertaking an 24 appeal, dispute resolution, or judicial review of an adverse 25 determination. 26 (m) In no event shall an enrollee, an enrollee's 27 designee, an enrollee's health care provider, any other 28 health care provider, or any other person or entity be 29 required to inform or contact the utilization review agent 30 prior to the provision of emergency services as defined in 31 this Act. 32 (n) No contract or agreement between a utilization 33 review agent and a health care provider shall contain any 34 clause purporting to transfer to the health care provider by HB0626 Engrossed -47- LRB9000248JSmb 1 indemnification or otherwise any liability relating to 2 activities, actions, or omissions of the utilization review 3 agent. 4 (o) A health care professional providing health care 5 services to an enrollee shall be prohibited from serving 6 as the clinical peer reviewer for that enrollee in connection 7 with the health care services being provided to the 8 enrollee. 9 Section 95. Annual consumer satisfaction survey. The 10 Director shall develop and administer a survey of persons who 11 have been enrolled in a managed care plan in the most recent 12 calendar year to collect information on relative plan 13 performance. This survey shall: 14 (1) be administered annually by the Director, or by 15 an independent agency or organization selected by the 16 Director; 17 (2) be administered to a scientifically selected 18 representative sample of current enrollees from each 19 plan, as well as persons who have disenrolled from a plan 20 in the last calendar year; and 21 (3) emphasize the collection of information from 22 persons who have used the managed care plan to a 23 significant degree, as defined by rule. 24 Selected data from the annual survey shall be made 25 available to current and prospective enrollees as part of a 26 consumer guidebook of health plan performance, which the 27 Department shall develop and publish. The elements to be 28 included in the guidebook shall be reassessed on an ongoing 29 basis by the Department. The consumer guidebook shall be 30 updated at least annually. 31 Section 100. Managed care patient rights. In addition 32 to all other requirements of this Act, a managed care plan HB0626 Engrossed -48- LRB9000248JSmb 1 shall ensure that an enrollee has the following rights: 2 (1) A patient has the right to care consistent with 3 professional standards of practice to assure quality nursing 4 and medical practices, to be informed of the name of the 5 participating physician responsible for coordinating his or 6 her care, to receive information concerning his or her 7 condition and proposed treatment, to refuse any treatment to 8 the extent permitted by law, and to privacy and 9 confidentiality of records except as otherwise provided by 10 law. 11 (2) A patient has the right, regardless of source of 12 payment, to examine and to receive a reasonable explanation 13 of his or her total bill for health care services rendered by 14 his or her physician or other health care provider, including 15 the itemized charges for specific health care services 16 received. A physician or other health care provider shall be 17 responsible only for a reasonable explanation of these 18 specific health care services provided by the health care 19 provider. 20 (3) A patient has the right to privacy and 21 confidentiality in health care. A physician, other health 22 care provider, managed care plan, and utilization review 23 agent shall refrain from disclosing the nature or details of 24 health care services provided to patients, except that the 25 information may be disclosed to the patient, the party making 26 treatment decisions if the patient is incapable of making 27 decisions regarding the health care services provided, those 28 parties directly involved with providing treatment to the 29 patient or processing the payment for the treatment, those 30 parties responsible for peer review, utilization review, and 31 quality assurance, and those parties required to be notified 32 under the Abused and Neglected Child Reporting Act, the 33 Illinois Sexually Transmissible Disease Control Act, or where 34 otherwise authorized or required by law. This right may be HB0626 Engrossed -49- LRB9000248JSmb 1 expressly waived in writing by the patient or the patient's 2 guardian, but a managed care plan, a physician, or other 3 health care provider may not condition the provision of 4 health care services on the patient's or guardian's agreement 5 to sign the waiver. 6 Section 105. Managed Care Ombudsman Program. 7 (a) The Department shall establish a Managed Care 8 Ombudsman Program (MCOP). The purpose of the MCOP is to 9 assist consumers to: 10 (1) navigate the managed care system; 11 (2) select an appropriate managed care plan; and 12 (3) understand and assert their rights and 13 responsibilities as managed care plan enrollees. 14 (b) The Department shall contract with an independent 15 organization or organizations to perform the following MCOP 16 functions: 17 (1) Assist consumers with managed care plan 18 selection by providing information, referral, and 19 assistance to individuals about means of obtaining health 20 coverage and services, including, but not limited to: 21 (A) access through a toll-free telephone 22 number; and 23 (B) availability of information in languages 24 other than English that are spoken as a primary 25 language by a significant portion of the State's 26 population, as determined by the Department. 27 (2) Educate and train consumers in the use of the 28 Department's annual Consumer Guidebook of Health Plan 29 Performance, compiled in accordance with Section 95. 30 (3) Analyze, comment on, monitor, and make publicly 31 available reports on the development and implementation 32 of federal, State and local laws, regulations, and other 33 governmental policies and actions that pertain to the HB0626 Engrossed -50- LRB9000248JSmb 1 adequacy of managed care plans, facilities, and services 2 in the State. 3 (4) Ensure that individuals have timely access to 4 the services provided through the MCOP. 5 (5) Submit an annual report to the Department and 6 General Assembly: 7 (A) describing the activities carried out by 8 the MCOP in the year for which the report is 9 prepared; 10 (B) containing and analyzing the data 11 collected by the MCOP; and 12 (C) evaluating the problems experienced by 13 managed care plan enrollees. 14 (6) Exercise such other powers and functions as the 15 Department determines to be appropriate. 16 (c) The Department shall establish criteria for 17 selection of an independent organization or organizations to 18 perform the functions of the MCOP, including, but not limited 19 to, the following: 20 (1) Preference shall be given to private, 21 not-for-profit organizations governed by boards with 22 consumer members in the majority that represent a broad 23 spectrum of the diverse consumer interests in the State. 24 (2) No individual or organization under contract to 25 perform functions of the MCOP may: 26 (A) have a direct involvement in the 27 licensing, certification, or accreditation of a 28 health care facility, a managed care plan, or a 29 provider of a managed care plan, or have a direct 30 involvement with a provider of a health care 31 service; 32 (B) have a direct ownership or investment 33 interest in a health care facility, a managed care 34 plan, or a health care service; HB0626 Engrossed -51- LRB9000248JSmb 1 (C) be employed by, or participate in the 2 management of, a health care service or facility or 3 a managed care plan; or 4 (D) receive, or have the right to receive, 5 directly or indirectly, remuneration (in cash or in 6 kind) under a compensation arrangement with an owner 7 or operator of a health care service or facility or 8 managed care plan. 9 The Department shall contract with an organization or 10 organizations qualified under criteria established under this 11 Section for an initial term of 3 years. The initial contract 12 shall be renewable thereafter for additional 3 year terms 13 without reopening the competitive selection process unless 14 there has been an unfavorable written performance evaluation 15 conducted by the Department. 16 (d) The Department shall establish, by rule, policies 17 and procedures for the operation of MCOP sufficient to ensure 18 that the MCOP can perform all functions specified in this 19 Section. 20 (e) The Department shall provide adequate funding for 21 the MCOP by assessing each managed care plan an amount to be 22 determined by the Department. 23 (f) Nothing in this Section shall be interpreted to 24 authorize access to or disclosure of individual patient or 25 provider records. 26 Section 110. Waiver. Any agreement that purports to 27 waive, limit, disclaim or in any way diminish the rights set 28 forth in this Act is void as contrary to public policy. 29 Section 115. Administration of Act. 30 (a) The Department shall administer the Act. 31 (b) All managed care plans and utilization review agents 32 providing or reviewing services in Illinois shall annually HB0626 Engrossed -52- LRB9000248JSmb 1 certify compliance with this Act and rules adopted under this 2 Act to the Department in addition to any other licensure 3 required by law. The Director shall establish by rule a 4 process for this certification including fees to cover the 5 costs associated with implementing this Act. All fees and 6 fines assessed under this Act shall be deposited in the 7 Managed Care Reform Fund, a special fund hereby created in 8 the State treasury. Moneys in the Fund shall be used by the 9 Department only to enforce and administer this Act. The 10 certification requirements of this Act shall be incorporated 11 into program requirements of the Department of Public Aid and 12 Department of Human Services and no further certification 13 under this Act is required. 14 (c) The Director shall take enforcement action under 15 this Act including, but not limited to, the assessment of 16 civil fines and injunctive relief for any failure to comply 17 with this Act or any violation of the Act or rules by a 18 managed care plan or any utilization review agent. 19 (d) The Department shall have the authority to impose 20 fines on any managed care plan or any utilization review 21 agent. The Department shall adopt rules pursuant to this Act 22 that establish a system of fines related to the type and 23 level of violation or repeat violation, including but not 24 limited to: 25 (1) A fine not exceeding $10,000 for a violation 26 that created a condition or occurrence presenting a 27 substantial probability that death or serious harm to an 28 individual will or did result therefrom; and 29 (2) A fine not exceeding $5,000 for a violation 30 that creates or created a condition or occurrence that 31 threatens the health, safety, or welfare of an 32 individual. 33 Each day a violation continues shall constitute a 34 separate offense. These rules shall include an opportunity HB0626 Engrossed -53- LRB9000248JSmb 1 for a hearing in accordance with the Illinois Administrative 2 Procedure Act. All final decisions of the Department shall 3 be reviewable under the Administrative Review Law. 4 (e) Notwithstanding the existence or pursuit of any 5 other remedy, the Director may, through the Attorney General, 6 seek an injunction to restrain or prevent any person or 7 entity from functioning or operating in violation of this Act 8 or rule. 9 Section 120. Emergency services. 10 (a) Any managed care plan subject to this Act shall 11 provide the enrollee emergency services coverage such that 12 payment for this coverage is not dependent upon whether such 13 services are performed by a participating or nonparticipating 14 provider, and such coverage shall be at the same benefit 15 level as if the service or treatment had been rendered by a 16 plan provider. Nothing in this Section is intended to 17 prohibit a plan from imposing its customary and normal 18 co-payments, deductibles, co-insurance, and other like 19 charges for emergency services. 20 (b) Prior authorization or approval by the plan shall 21 not be required for emergency services rendered under this 22 Section. 23 (c) Coverage and payment shall not be retrospectively 24 denied, with the following exceptions: 25 (1) upon reasonable determination that the 26 emergency services claimed were never performed; or 27 (2) upon reasonable determination that an emergency 28 medical screening examination was performed on a patient 29 who personally sought emergency services knowing that he 30 or she did not have an emergency condition or necessity, 31 and who did not in fact require emergency services. 32 (d) When an enrollee presents to a hospital seeking 33 emergency services, as defined in this Act, the determination HB0626 Engrossed -54- LRB9000248JSmb 1 as to whether the need for those services exists shall be 2 made for purposes of treatment by a physician or, to the 3 extent permitted by applicable law, by other appropriate 4 licensed personnel under the supervision of a physician. The 5 physician or other appropriate personnel shall indicate in 6 the patient's chart the results of the emergency medical 7 screening examination. The plan shall compensate the 8 provider for an emergency medical screening examination that 9 is reasonably calculated to assist the health care provider 10 in determining whether the patient's condition requires 11 emergency services. A plan shall have no duty to pay for 12 services rendered after an emergency medical screening 13 examination determines the lack of a need for emergency 14 services. 15 (e) The appropriate use of the 911 emergency telephone 16 number shall not be discouraged or penalized, and coverage or 17 payment shall not be denied solely on the basis that the 18 insured used the 911 emergency telephone number to summon 19 emergency services. 20 (f) If prior authorization for post-stabilization 21 services, as defined in this Act, is required, the managed 22 care plan shall provide access 24 hours a day, 7 days a week 23 to persons designated by plan to make such determinations. 24 If a provider has attempted to contact such person for prior 25 authorization and no designated persons were accessible or 26 the authorization was not denied within one hour of the 27 request, the plan is deemed to have approved the request for 28 prior authorization. 29 (g) Coverage and payment for post-stabilization services 30 which received prior authorization or deemed approval shall 31 not be retrospectively denied. Nothing in this Section is 32 intended to prohibit a plan from imposing its customary and 33 normal co-payments, deductibles, co-insurance, and other like 34 changes for post-stabilization services. HB0626 Engrossed -55- LRB9000248JSmb 1 Section 125. Prescription drugs. A managed care plan 2 that provides coverage for prescribed drugs approved by the 3 federal Food and Drug Administration shall not exclude 4 coverage of any drug on the basis that the drug has been 5 prescribed for the treatment of a particular indication for 6 which the drug has not been approved by the federal Food and 7 Drug Administration. The drug, however, must be approved by 8 the federal Food and Drug Administration and must be 9 recognized for the treatment of that particular indication 10 for which the drug has been prescribed in any one of the 11 following established reference compendia: 12 (1) the American Hospital Formulary Service Drug 13 Information; 14 (2) the United States Pharmacopoeia Drug 15 Information; or 16 (3) if not recognized by the authorities in item 17 (1) or (2), recommended for that particular indication in 18 formal clinical studies, the results of which have been 19 published in at least 2 peer reviewed professional 20 medical journals published in the United States or Great 21 Britain. 22 Any coverage required by this Section shall also include 23 those medically necessary services associated with the 24 administration of a drug. 25 Despite the provisions of this Section, coverage shall 26 not be required for any experimental or investigational drugs 27 or any drug that the federal Food and Drug Administration has 28 determined to be contraindicated for treatment of the 29 specific indication for which the drug has been prescribed. 30 Nothing in this Section shall be construed, expressly or by 31 implication, to create, impair, alter, limit, notify, 32 enlarge, abrogate, or prohibit reimbursement for drugs used 33 in the treatment of any other disease or condition. HB0626 Engrossed -56- LRB9000248JSmb 1 Section 130. Health Care Service Delivery Review Board. 2 (a) A managed care plan shall organize a Health Care 3 Service Delivery Review Board from participants in the plan. 4 The Board shall consist of 17 members: 5 participating 5 physicians elected by participating physicians, 5 other 6 participating providers elected by the other health care 7 providers, 5 enrollees elected by the enrollees, and 2 8 representatives of the plan appointed by the plan. The 9 representatives of the plan shall not have a vote on the 10 Board, but shall have all other rights granted to Board 11 members. The plan shall devise a mechanism for the election 12 of the Board's members, subject to the approval of the 13 Department. The Department shall not unreasonably withhold 14 its approval of a mechanism. 15 (b) The Health Care Service Delivery Board shall 16 establish written rules and regulations governing its 17 operation. The managed care plan shall approve the rules, 18 but may not unilaterally amend them. A plan may not 19 unreasonably withhold approval of proposed rules and 20 regulations. 21 (c) The Health Care Service Delivery Board shall, from 22 time to time, issue nonbinding reports and reviews concerning 23 the plan's health care delivery policy, quality assurance 24 procedures, utilization review criteria and procedures, and 25 medical management procedures. The Board shall select the 26 aspects of the plan that it wishes to study or review and may 27 undertake a study or review at the request of the plan. The 28 Board shall issue its report directly to the managed care 29 plan's governing board. 30 Section 135. Conflicts with federal law. When health 31 care services are provided by a managed care plan subject to 32 this Act to a person who is a recipient of medical assistance 33 under Article V of the Illinois Public Aid Code, the rights, HB0626 Engrossed -57- LRB9000248JSmb 1 benefits, requirements, and procedures available or 2 authorized under this Act shall not apply to the extent that 3 there are provisions of federal law that conflict. In the 4 event of a conflict, federal law shall prevail. 5 Section 140. The State Employees Group Insurance Act of 6 1971 is amended by adding Section 6.9 as follows: 7 (5 ILCS 375/6.9 new) 8 Sec. 6.9. Managed Care Reform Act. The program of 9 health benefits is subject to the provisions of the Managed 10 Care Reform Act. 11 Section 145. The State Finance Act is amended by adding 12 Section 5.449 as follows: 13 (30 ILCS 105/5.449 new) 14 Sec. 5.449. The Managed Care Reform Fund. 15 Section 150. The State Mandates Act is amended by adding 16 Section 8.21 as follows: 17 (30 ILCS 805/8.21 new) 18 Sec. 8.21. Exempt mandate. Notwithstanding Sections 6 19 and 8 of this Act, no reimbursement by the State is required 20 for the implementation of any mandate created by this 21 amendatory Act of 1997. 22 Section 155. The Counties Code is amended by adding 23 Section 5-1069.8 as follows: 24 (55 ILCS 5/5-1069.8 new) 25 Sec. 5-1069.8. Managed Care Reform Act. All counties, 26 including home rule counties, are subject to the provisions HB0626 Engrossed -58- LRB9000248JSmb 1 of the Managed Care Reform Act. The requirement under this 2 Section that health care benefits provided by counties comply 3 with the Managed Care Reform Act is an exclusive power and 4 function of the State and is a denial and limitation of home 5 rule county powers under Article VII, Section 6, subsection 6 (h) of the Illinois Constitution. 7 Section 160. The Illinois Municipal Code is amended by 8 adding 10-4-2.8 as follows: 9 (65 ILCS 5/10-4-2.8 new) 10 Sec. 10-4-2.8. Managed Care Reform Act. The corporate 11 authorities of all municipalities are subject to the 12 provisions of the Managed Care Reform Act. The requirement 13 under this Section that health care benefits provided by 14 municipalities comply with the Managed Care Reform Act is an 15 exclusive power and function of the State and is a denial and 16 limitation of home rule municipality powers under Article 17 VII, Section 6, subsection (h) of the Illinois Constitution. 18 Section 165. The School Code is amended by adding 19 Section 10-22.3f as follows: 20 (105 ILCS 5/10-22.3f new) 21 Sec. 10-22.3f. Managed Care Reform Act. Insurance 22 protection and benefits for employees are subject to the 23 Managed Care Reform Act. 24 Section 170. The Health Maintenance Organization Act is 25 amended by changing Sections 2-2 and 6-7 as follows: 26 (215 ILCS 125/2-2) (from Ch. 111 1/2, par. 1404) 27 Sec. 2-2. Determination by Director; Health Maintenance 28 Advisory Board. HB0626 Engrossed -59- LRB9000248JSmb 1 (a) Upon receipt of an application for issuance of a 2 certificate of authority, the Director shall transmit copies 3 of such application and accompanying documents to the 4 Director of the Illinois Department of Public Health. The 5 Director of the Department of Public Health shall then 6 determine whether the applicant for certificate of authority, 7 with respect to health care services to be furnished: (1) has 8 demonstrated the willingness and potential ability to assure 9 that such health care service will be provided in a manner to 10 insure both availability and accessibility of adequate 11 personnel and facilities and in a manner enhancing 12 availability, accessibility, and continuity of service; and 13 (2) has arrangements, established in accordance with rules 14regulationspromulgated by the Department of Public Health 15 for an ongoing quality of health care assurance program 16 concerning health care processes and outcomes. Upon 17 investigation, the Director of the Department of Public 18 Health shall certify to the Director whether the proposed 19 Health Maintenance Organization meets the requirements of 20 this subsection (a). If the Director of the Department of 21 Public Health certifies that the Health Maintenance 22 Organization does not meet such requirements, he or she shall 23 specify in what respect it is deficient. 24 There is created in the Department of Public Health a 25 Health Maintenance Advisory Board composed of 11 members. 26 Nine of the 119members shallwhohave practiced in the 27 health field and,4 of those 9whichshall have been or shall 28 bearecurrently affiliated with a Health Maintenance 29 Organization. Two of the members shall be members of the 30 general public, one of whom is over 65 years of age. Each 31 member shall be appointed by the Director of the Department 32 of Public Health and serve at the pleasure of that Director 33 and shall receive no compensation for services rendered other 34 than reimbursement for expenses. SixFivemembers of the HB0626 Engrossed -60- LRB9000248JSmb 1 Board shall constitute a quorum. A vacancy in the membership 2 of the Advisory Board shall not impair the right of a quorum 3 to exercise all rights and perform all duties of the Board. 4 The Health Maintenance Advisory Board has the power to review 5 and comment on proposed rulesand regulationsto be 6 promulgated by the Director of the Department of Public 7 Health within 30 days after those proposed rulesand8regulationshave been submitted to the Advisory Board. 9 (b) Issuance of a certificate of authority shall be 10 granted if the following conditions are met: 11 (1) the requirements of subsection (c) of Section 12 2-1 have been fulfilled; 13 (2) the persons responsible for the conduct of the 14 affairs of the applicant are competent, trustworthy, and 15 possess good reputations, and have had appropriate 16 experience, training or education; 17 (3) the Director of the Department of Public Health 18 certifies that the Health Maintenance Organization's 19 proposed plan of operation meets the requirements of this 20 Act; 21 (4) the Health Care Plan furnishes basic health 22 care services on a prepaid basis, through insurance or 23 otherwise, except to the extent of reasonable 24 requirements for co-payments or deductibles as authorized 25 by this Act; 26 (5) the Health Maintenance Organization is 27 financially responsible and may reasonably be expected to 28 meet its obligations to enrollees and prospective 29 enrollees; in making this determination, the Director 30 shall consider: 31 (A) the financial soundness of the applicant's 32 arrangements for health services and the minimum 33 standard rates, co-payments and other patient 34 charges used in connection therewith; HB0626 Engrossed -61- LRB9000248JSmb 1 (B) the adequacy of working capital, other 2 sources of funding, and provisions for 3 contingencies; and 4 (C) that no certificate of authority shall be 5 issued if the initial minimum net worth of the 6 applicant is less than $2,000,000. The initial net 7 worth shall be provided in cash and securities in 8 combination and form acceptable to the Director; 9 (6) the agreements with providers for the provision 10 of health services contain the provisions required by 11 Section 2-8 of this Act; and 12 (7) any deficiencies identified by the Director 13 have been corrected. 14 (Source: P.A. 86-620; 86-1475.) 15 (215 ILCS 125/6-7) (from Ch. 111 1/2, par. 1418.7) 16 Sec. 6-7. Board of Directors. The board of directors of 17 the Association shall consistconsistsof not less than 7518 nor more than 119members serving terms as established in 19 the plan of operation. The members of the board are to be 20 selected by member organizations subject to the approval of 21 the Director provided, however, that 2 members shall be 22 enrollees, one of whom is over 65 years of age. Vacancies on 23 the board must be filled for the remaining period of the term 24 in the manner described in the plan of operation. To select 25 the initial board of directors, and initially organize the 26 Association, the Director must give notice to all member 27 organizations of the time and place of the organizational 28 meeting. In determining voting rights at the organizational 29 meeting each member organization is entitled to one vote in 30 person or by proxy. If the board of directors is not 31 selected at the organizational meeting, the Director may 32 appoint the initial members. 33 In approving selections or in appointing members to the HB0626 Engrossed -62- LRB9000248JSmb 1 board, the Director must consider, whether all member 2 organizations are fairly represented. 3 Members of the board may be reimbursed from the assets of 4 the Association for expenses incurred by them as members of 5 the board of directors but members of the board may not 6 otherwise be compensated by the Association for their 7 services. 8 (Source: P.A. 85-20.) 9 Section 175. Severability. The provisions of this Act 10 are severable under Section 1.31 of the Statute on Statutes. 11 Section 199. Effective date. This Act takes effect July 12 1, 1998.